“…While drug-design efforts targeting PTKs have resulted in the development of many inhibitors that are used in the clinic today, medicinal chemistry efforts targeting PTPs lag far behind and remain very challenging. Nevertheless, several PTPs have the potential to serve as important drug targets for a variety of diseases such as cancer, diabetes, neurological and autoimmune disorders, inflammation and numerous pathogenic infections (Blaskovich, 2009;Bialy & Waldmann, 2005;Tautz et al, 2006;Alonso et al, 2004;Mustelin, 2006;Bahta & Burke, 2012;Guan & Dixon, 1993;Zhou et al, 2010;Bö hmer et al, 2013). PTPs are generally considered to be difficult targets for therapeutic intervention, in part because of their highly conserved active sites.…”